Disposable Reflective Marker Spheres ישראל - עברית - Ministry of Health

disposable reflective marker spheres

voyant health ltd. - צוות טכני - disposable reflective marker spheres are intended to detect instrument coordinates and patient position with diagnostic imaging during treatment

מבטרה 10 מגמל תוך ורידי ישראל - עברית - Ministry of Health

מבטרה 10 מגמל תוך ורידי

roche pharmaceuticals (israel) ltd - rituximab - תרכיז להכנת תמיסה לאינפוזיה - rituximab 10 mg/ml - rituximab - rituximab - mabthera is indicated for the following indications: * non-hodgkin’s lymphoma (nhl)mabthera is indicated for the treatment of patients with relapsed or refractory low-grade or follicular, b-cell non-hodgkin’s lymphoma.mabthera is indicated for the treatment of previously untreated patients with low-grade or follicular lymphoma in combination with chemotherapy mabthera is indicated for the treatment of patients with cd20 positive diffuse large b-cell non-hodgkin's lymphoma in combination with chop chemotherapy. mabthera maintenance therapy is indicated for the treatment of follicular lymphoma patients responding to induction therapy. * chronic lymphocytic leukaemia (cll)mabthera in combination with chemotherapy is indicated for the treatment of patients with previously untreated and relapsed/refractory chronic lymphocytic leukaemia. only limited data are available on efficacy and safety for patients previously treated with monoclonal antibodies including mabthera or patients refractory to previous mabthera plu

קסאלקורי 200 מג ישראל - עברית - Ministry of Health

קסאלקורי 200 מג

pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.

קסאלקורי 200 מג ישראל - עברית - Ministry of Health

קסאלקורי 200 מג

pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 200 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.

קסאלקורי 250 מג ישראל - עברית - Ministry of Health

קסאלקורי 250 מג

pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.

קסאלקורי 250 מג ישראל - עברית - Ministry of Health

קסאלקורי 250 מג

pfizer pharmaceuticals israel ltd - crizotinib - קפסולות - crizotinib 250 mg - crizotinib - crizotinib - xalkori is indicated for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc) that is anaplastic lymphoma kinase (alk)-positive.

טייקרב ישראל - עברית - Ministry of Health

טייקרב

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.

SomnuSeal™ ישראל - עברית - Ministry of Health

somnuseal™

discover medical devices ltd. - כלל האוכלוסיה - somnuseal device is intended for multiuse purposes to provide positive air pressure (pap) treatment to a single patient or multiple patients, as a pap interface in hospitals/clinics and/or home use provided that the user was diagnosed by a physician to require pap treatment.

ETView VivaSight DL ישראל - עברית - Ministry of Health

etview vivasight dl

etview ltd. - רופא - the etview vivasight dl is intended to isolate the left or right lung of a patient for intensive care or surgery, one lung ventilation or one lung anesthesia. the vivasight dl system is indicated for verifying tube placement and repositioning.

HASKAL TORQUE DEVICE ישראל - עברית - Ministry of Health

haskal torque device

elcam medical acal - רופא - the haskal torque device is intended to facilitate steering of guidwires during interventional procedures. it is designed to be easily mounted onto any segment of a guidwire (without having to thread it on from the back end) and repositioned in a simple one-handed manner.